| VKTX |
Viking Therapeutics, Inc. |
Lian Brian |
|
2026-01-05 |
S - D |
41,276 |
34.22 |
1,412,398.68 |
2,505,691 |
| VKTX |
Viking Therapeutics, Inc. |
Lian Brian |
|
2026-01-05 |
S - D |
6,400 |
35.07 |
224,423.04 |
2,499,291 |
| VKTX |
Viking Therapeutics, Inc. |
Mancini Marianna |
|
2026-01-05 |
S - D |
31,961 |
32.29 |
1,032,110.18 |
434,890 |
| VKTX |
Viking Therapeutics, Inc. |
Mancini Marianna |
|
2026-01-05 |
S - D |
13,600 |
33.37 |
453,875.52 |
421,290 |
| VKTX |
Viking Therapeutics, Inc. |
Mancini Marianna |
|
2026-01-05 |
S - D |
10,500 |
34.22 |
359,302.65 |
410,790 |
| VKTX |
Viking Therapeutics, Inc. |
Mancini Marianna |
|
2026-01-05 |
S - D |
1,600 |
35.07 |
56,116.96 |
409,190 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
31,961 |
32.30 |
1,032,180.50 |
215,571 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
13,900 |
33.38 |
464,020.92 |
201,671 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
10,300 |
34.24 |
352,634.92 |
191,371 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
1,500 |
32.09 |
48,133.05 |
189,891 |
| CNS |
COHEN & STEERS, INC. |
Villani Edmond D |
Director
|
2026-01-05 |
G - D |
419 |
0.00 |
0.00 |
4,606 |
| CNS |
COHEN & STEERS, INC. |
Villani Edmond D |
Director
|
2026-01-05 |
G - A |
419 |
0.00 |
0.00 |
30,678 |
| TNON |
Tenon Medical, Inc. |
WEIGLE ROBERT K |
Director
|
2026-01-05 |
F - D |
3,413 |
0.93 |
3,174.43 |
7,552 |
| GLUE |
Monte Rosa Therapeutics, Inc. |
Warmuth Markus |
|
2026-01-05 |
S - D |
10,135 |
15.17 |
153,747.95 |
624,403 |
| W |
Wayfair Inc. |
Blotner Jon |
Officer
|
2026-01-05 |
S - D |
4,997 |
105.84 |
528,882.48 |
106,107 |
| TNON |
Tenon Medical, Inc. |
Williamson Kevin |
Director
Officer
|
2026-01-05 |
F - D |
18,518 |
0.93 |
17,243.96 |
42,552 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
31,961 |
32.30 |
1,032,180.50 |
215,571 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
13,900 |
33.38 |
464,020.92 |
201,671 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
10,300 |
34.24 |
352,634.92 |
191,371 |
| VKTX |
Viking Therapeutics, Inc. |
ZANTE GREG |
|
2026-01-05 |
S - D |
1,500 |
32.09 |
48,133.05 |
189,891 |
|
OneSpan Inc. |
Zenner Marc |
Director
|
2026-01-05 |
A - A |
9,797 |
0.00 |
0.00 |
9,797 |
| ZYME |
Zymeworks Inc. |
Moore Paul Andrew |
|
2026-01-05 |
M - A |
17,168 |
0.00 |
0.00 |
40,501 |
| ZYME |
Zymeworks Inc. |
Moore Paul Andrew |
|
2026-01-05 |
S - D |
9,289 |
25.10 |
233,125.10 |
31,212 |
| ZYME |
Zymeworks Inc. |
Moore Paul Andrew |
|
2026-01-05 |
M - A |
20,000 |
0.00 |
0.00 |
51,212 |
| ZYME |
Zymeworks Inc. |
Moore Paul Andrew |
|
2026-01-05 |
S - D |
10,821 |
25.10 |
271,573.55 |
40,391 |